.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Covington
Cipla
QuintilesIMS
Harvard Business School
Merck
McKinsey
Federal Trade Commission
Farmers Insurance

Generated: September 19, 2017

DrugPatentWatch Database Preview

Ajanta Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for AJANTA PHARMA, and what generic and branded alternatives to AJANTA PHARMA drugs are available?

AJANTA PHARMA has twenty approved drugs.

There is one tentative approval on AJANTA PHARMA drugs.

Summary for Applicant: Ajanta Pharma

Patents:0
Tradenames:16
Ingredients:16
NDAs:20
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd
MONTELUKAST SODIUM
montelukast sodium
TABLET;ORAL203432-001Jul 31, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
DULOXETINE HYDROCHLORIDE
duloxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL208706-001Jan 6, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL204041-001May 20, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
OLANZAPINE
olanzapine
TABLET;ORAL206711-005Aug 30, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma
LEVETIRACETAM
levetiracetam
TABLET;ORAL201293-001Jun 14, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
AMLODIPINE AND OLMESARTAN MEDOXOMIL
amlodipine besylate; olmesartan medoxomil
TABLET;ORAL207216-002Oct 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
OLANZAPINE
olanzapine
TABLET;ORAL206711-003Aug 30, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL205523-002Mar 3, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
VORICONAZOLE
voriconazole
TABLET;ORAL206181-002May 24, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
OLANZAPINE
olanzapine
TABLET;ORAL206711-001Aug 30, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Colorcon
Dow
AstraZeneca
Merck
Novartis
Cipla
Express Scripts
Covington
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot